Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Issue 11 (25th November 2021)

Record Type:
Journal Article
Title:
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Issue 11 (25th November 2021)
Main Title:
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO
Authors:
Oliva-Damaso, Nestor
Bomback, Andrew S.
Abstract:
Is Part Of:
Kidney360. Volume 2:Issue 11(2021)
Journal:
Kidney360
Issue:
Volume 2:Issue 11(2021)
Issue Display:
Volume 2, Issue 11 (2021)
Year:
2021
Volume:
2
Issue:
11
Issue Sort Value:
2021-0002-0011-0000
Page Start:
1696
Page End:
1698
Publication Date:
2021-11-25
Subjects:
glomerular and tubulointerstitial diseases -- cyclophosphamide -- immunosuppressive agents -- membranous glomerulonephritis -- rituximab
616.61
Journal URLs:
https://www.asn-online.org/ ↗
DOI:
10.34067/KID.0001842021 ↗
Languages:
English
ISSNs:
2641-7650
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
26799.xml